Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Net Margin (2019 - 2025)

Biodesix's Net Margin history spans 7 years, with the latest figure at 14.0% for Q4 2025.

  • For Q4 2025, Net Margin rose 2712.0% year-over-year to 14.0%; the TTM value through Dec 2025 reached 40.21%, up 1973.0%, while the annual FY2025 figure was 40.21%, 1973.0% up from the prior year.
  • Net Margin reached 14.0% in Q4 2025 per BDSX's latest filing, up from 41.92% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 14.0% in Q4 2025 to a low of 238.21% in Q1 2022.
  • Average Net Margin over 5 years is 102.5%, with a median of 81.15% recorded in 2024.
  • Peak YoY movement for Net Margin: surged 17226bps in 2021, then plummeted -21661bps in 2022.
  • A 5-year view of Net Margin shows it stood at 182.38% in 2021, then increased by 6bps to 171.13% in 2022, then skyrocketed by 63bps to 62.71% in 2023, then skyrocketed by 34bps to 41.12% in 2024, then soared by 66bps to 14.0% in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Net Margin are 14.0% (Q4 2025), 41.92% (Q3 2025), and 58.03% (Q2 2025).